Ex-DeepMind researchers raised $50M to build AI that figures out which scientific questions are worth asking
What happened
London-based AI startup Inherent has raised $50 million in a seed round to develop artificial intelligence that can identify which scientific questions are worth investigating. The funding round was co-led by Index Ventures and Radical Ventures, with Nvidia’s venture arm NVentures and several other investors joining. The founding team includes researchers from DeepMind, Microsoft, and other AI-heavy organizations. The company emerged from stealth mode in early 2026.
Why it matters
Scientific research often faces a bottleneck in choosing which questions to prioritize, limiting how fast new discoveries emerge. Inherent aims to use AI to sift through vast scientific data and propose the most promising, high-impact questions for research. For funding bodies, research institutions, and companies that rely on science-driven innovation, this could dramatically improve how resources are allocated. It could reduce wasted effort on low-value investigations and accelerate breakthroughs in medicine, materials, climate science, and more. The scale of funding also signals strong investor confidence in AI’s growing role in scientific decision-making, not just automation.
What to watch next
The next key development will be how Inherent’s AI performs in real-world research environments and whether it can live up to its promise of enhancing decision-making for scientists and funders. Operators and investors should watch for early partnerships with research institutions or pharma companies since application in these sectors will drive adoption. Also, how Inherent navigates the challenge of AI interpretability and trust with researchers will be critical to gaining traction. This round raises the stakes for other AI startups trying to influence science policy and strategy beyond automating routine tasks.
AI Quick Briefs Editorial Desk
